✦ LIBER ✦

Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens

✍ Scribed by Eleftherakis-Papapiakovou, Evangelos; Kastritis, Esftathios; Roussou, Maria; Gkotzamanidou, Maria; Grapsa, Irini; Psimenou, Erasmia; Nikitas, Nikitas; Terpos, Evangelos; Dimopoulos, Meletios A.

Book ID: 120252651
Publisher: Informa plc
Year: 2011
Tongue: English
Weight: 413 KB
Volume: 52
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2011.597906

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reversibility of Renal Impairment in Pat

Reversibility of Renal Impairment in Patients With Multiple Myeloma Treated With Bortezomib-Based Regimens: Identification of Predictive Factors

✍ Dimopoulos, Meletios A.; Roussou, Maria; Gavriatopoulou, Maria; Zagouri, Flora; 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 115 KB

1q21 amplification with additional genet

1q21 amplification with additional genetic abnormalities but not isolated 1q21 gain is a negative prognostic factor in newly diagnosed patients with multiple myeloma treated with thalidomide-based regimens

✍ Grzasko, Norbert; Hus, Marek; Chocholska, Sylwia; Pluta, Andrzej; Hajek, Roman; 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 265 KB

Circulating angiopoietin-1 to angiopoiet

Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents

✍ Evangelos Terpos; Konstantinos Anargyrou; Eirini Katodritou; Efstathios Kastriti 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB 👁 1 views

## Abstract The circulating levels of several angiogenic cytokines [angiopoietin‐1 (Ang‐1), angiopoietin‐2 (Ang‐2), vascular endothelial growth factor (VEGF), angiogenin and basic fibroblast growth factor (bFGF)] were evaluated in 174 consecutive patients with newly diagnosed, symptomatic, multiple